Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

FAB

Fusion Antibodies (FAB)

Fusion Antibodies Plc
일자:
정렬 기준:
 검색 관련기사 보기:LSE:FAB
일자시간출처헤드라인심볼기업
2025/01/3116:00RNS Regulatory NewsFusion Antibodies PLC OptiMAL R&D UpdateLSE:FABFusion Antibodies Plc
2024/12/0421:18Alliance NewsAlliance NewsFusion Antibodies receives approval of grant funding applicationLSE:FABFusion Antibodies Plc
2024/12/0420:31RNS Regulatory NewsFusion Antibodies PLC Approval of Grant Funding ApplicationLSE:FABFusion Antibodies Plc
2024/11/1922:10Alliance NewsAlliance NewsFusion Antibodies interim loss narrows as revenue more than doublesLSE:FABFusion Antibodies Plc
2024/11/1916:00RNS Regulatory NewsFusion Antibodies PLC Half-year ReportLSE:FABFusion Antibodies Plc
2024/10/1621:23RNS Regulatory NewsFusion Antibodies PLC Director/PDMR ShareholdingLSE:FABFusion Antibodies Plc
2024/10/1615:00RNS Regulatory NewsFusion Antibodies PLC Issue of shares to non-executive directorsLSE:FABFusion Antibodies Plc
2024/10/0821:58Alliance NewsAlliance NewsIN BRIEF: Fusion Antibodies expects interim revenue to doubleLSE:FABFusion Antibodies Plc
2024/10/0820:32RNS Regulatory NewsFusion Antibodies PLC Result of AGMLSE:FABFusion Antibodies Plc
2024/10/0815:00RNS Regulatory NewsFusion Antibodies PLC AGM statement and trading updateLSE:FABFusion Antibodies Plc
2024/10/0215:00RNS Regulatory NewsFusion Antibodies PLC Block admission six monthly returnLSE:FABFusion Antibodies Plc
2024/09/1217:54RNS Regulatory NewsFusion Antibodies PLC Notice of AGMLSE:FABFusion Antibodies Plc
2024/09/0920:35RNS Regulatory NewsFusion Antibodies PLC Director/PDMR ShareholdingLSE:FABFusion Antibodies Plc
2024/09/0915:00RNS Non-RegulatoryFusion Antibodies PLC Investor presentationLSE:FABFusion Antibodies Plc
2024/09/0520:15RNS Regulatory NewsFusion Antibodies PLC Director/PDMR ShareholdingLSE:FABFusion Antibodies Plc
2024/09/0515:00RNS Regulatory NewsFusion Antibodies PLC Final ResultsLSE:FABFusion Antibodies Plc
2024/08/2821:52Alliance NewsAlliance NewsFusion Antibodies expands agreement with National Cancer InstituteLSE:FABFusion Antibodies Plc
2024/08/2815:00RNS Non-RegulatoryFusion Antibodies PLC Expansion to OptiMAL collaboration agreementLSE:FABFusion Antibodies Plc
2024/07/2220:54RNS Regulatory NewsFusion Antibodies PLC Director/PDMR ShareholdingLSE:FABFusion Antibodies Plc
2024/07/1815:00RNS Non-RegulatoryFusion Antibodies PLC Launch of New Interactive Investor HubLSE:FABFusion Antibodies Plc
2024/07/0421:33Alliance NewsAlliance NewsTRADING UPDATES: itim signs contract; Tekmar renews banking facilitiesLSE:FABFusion Antibodies Plc
2024/07/0415:00RNS Regulatory NewsFusion Antibodies PLC Trading updateLSE:FABFusion Antibodies Plc
2024/05/2405:08Alliance NewsAlliance NewsTRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pactLSE:FABFusion Antibodies Plc
2024/05/2315:00RNS Regulatory NewsFusion Antibodies PLC New contract with existing clientLSE:FABFusion Antibodies Plc
2024/05/0215:00RNS Non-RegulatoryFusion Antibodies PLC Investor presentationLSE:FABFusion Antibodies Plc
2024/05/0103:54Alliance NewsAlliance NewsEARNINGS AND TRADING: Software Circle & Beximco report higher revenueLSE:FABFusion Antibodies Plc
2024/04/3015:00RNS Regulatory NewsFusion Antibodies PLC Year-end trading statementLSE:FABFusion Antibodies Plc
2024/04/1615:00RNS Regulatory NewsFusion Antibodies PLC Change of auditorLSE:FABFusion Antibodies Plc
2024/04/1521:29Alliance NewsAlliance NewsFusion Antibodies inks commercial contract for OptiPhage libraryLSE:FABFusion Antibodies Plc
2024/04/1515:00RNS Regulatory NewsFusion Antibodies PLC Contract to develop a bespoke OptiPhage libraryLSE:FABFusion Antibodies Plc
 검색 관련기사 보기:LSE:FAB